Kuhner shaker
keyboard_backspaceBack to Home
Contact
44 avenue Paul Kruger
69100 Villeurbanne
France
Responsable technico commercial
About us
Kuhner is a company specializing in the design and manufacture of the most reliable shakers, which can be automated and provide ideal solutions from R&D to GMP sites.
Founded in Switzerland in 1949, this family business is renowned for its high-quality equipment, combining innovation and reliability to optimize cell culture and microbiological processes.
Kuhner shakers are used in various sectors, including pharmaceutical research, vaccine production, and the development of advanced biotechnological solutions.
Its French subsidiary, Kuhner Shaker SARL, offers the entire range of Kuhner products on the French market.
Business offer
- Kuhner offers a complete range of shakers, incubator shakers and orbital shaken bioreactors, including a series of solutions specifically designed for automation:
- - New MPS-Z Automated: fully automated microtiter plates shaker
- - ISF1-Z incubator shaker range: temperature, humidity, and CO₂ control, Beluga model for automation
- - LT-X incubator shaker
- - Single-use orbital shaken bioreactors from 3L to 2500L: SB10-X, SB50-X, SB200-X, and SB2500-Z, easy scale up
- - Kuhner Kelvin+: compact benchtop incubator shaker
- - LS-Z benchtop shaker
- - Kuhner TOM: online measurement system
- - Feeding technology: efficient high-throughput screenings in fed-batch mode
- - Duetz system: for cultures in microtiter plates
- The «Kuhner shaker» name stands for functionality, reliability and durability. Kuhner guarantees its machines for 5 years, designing and building many components in-house. All processes are SN EN ISO 9001 certified.
- Kuhner offers a personal service for customers including product information, support and on-site visits.
Activities
- Technology Supplier
- Hit discovery
- Screening & Identification
- Therapeutic libraries
- In silico
- In-vivo models
- In-vitro & ex-vivo models
- CMC
- GLP compliance
- GLP compliance
- Cell Culture
- Bioreactor conditions
- Cell expansion
- Stirred tank reactors
- Bioproduction
- Batches production type
- Mammalian
- Insect
- Yeast
- Bacterial
- GLP compliance
- GMP compliance
- Volume
- Preclinical / Tox
- Low volume (< 200 L)
- High volume (200 – 2000 L)
- Very high volume (> 2000 L)
- Commercial
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- Quality assurance, quality control & analytical process
- Stability Assessment
- Shear/shaking
- pH
- Freeze/thaw
- Heat/degradation
- Bioproduction analytical test
- Monitoring
- Characterization
- Bioproduction engineering
- Cell Expansion
- Stirred tank Bioreactor
- Scale-Up
- Process optimization
- Automated manufacturing
- On-line monitoring
- Non-GMP expansion
- GMP expansion
- Bioproduction modeling
- Global optimization
- Delivery
- Transport
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Bioproduction
- Scale-Up
- Automated manufacturing
- Non-GMP pilot batch
- GMP batch
- Sterility
- Quality control
- Vaccine: antigen format platforms
- Recombinant protein expression
- Bacterial
- Cell
- Fungi
- Killed/inactivated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- CMC
- Cell Culture / Fermentation
- Bioreactor conditions (cell in suspension, adherent cell player)
- Cell expansion
- Single use technology (SUS)
- Stirred tank reactors
- Gene modification / Transduction
- Expression systems
- Bioproduction GMP
- Vaccine platform type
- Recombinant protein expression
- Synthetic Peptides or oligomers
- Virus-like particles (VLP) and nanoparticle-based carriers
- killed/inactivated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- Outer-membrane vesicles (OMV)
- Polysaccharides/ conjugated vaccines
- Pilot Batches scale
- Process development & optimization
- Scale-Up & Validation
- Comparability characterization protocol
- Manufacturing Volume
- Small volume (< 100 L) adjusted to phase I/II needs: specify volume
- Large volume (100 – 1000 L) adapted for phase III needs
- Final scale up volume (> 1000 L) and validation for manufacturing
- Commercial supply during life cycle management
